ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00506402
Recruitment Status : Completed
First Posted : July 25, 2007
Last Update Posted : May 5, 2009
Sponsor:
Information provided by:
CASI Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2009
  Actual Study Completion Date : April 2009